Select Medical (SEM)
(Delayed Data from NYSE)
$33.70 USD
+0.56 (1.69%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $33.68 -0.02 (-0.06%) 7:58 PM ET
5-Strong Sell of 5 5
B Value A Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$33.70 USD
+0.56 (1.69%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $33.68 -0.02 (-0.06%) 7:58 PM ET
5-Strong Sell of 5 5
B Value A Growth B Momentum A VGM
Zacks News
7 Reasons Why Select Medical (SEM) Stock Looks Attractive
by Zacks Equity Research
Select Medical (SEM) looks a profitable investment bet on the back of its top-line growth, backed by a solid financial position as well as acquisitions and joint ventures.
Is Select Medical (SEM) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Select Medical (SEM) Q2 Earnings Beat, Raises '21 EPS View
by Zacks Equity Research
Select Medical's (SEM) second-quarter results reflect strong top-line growth, higher admissions and increased patient visits, partly offset by elevated costs.
Select Medical (SEM) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Select Medical (SEM) delivered earnings and revenue surprises of 103.33% and 3.43%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Select Medical (SEM) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Select Medical (SEM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Encompass Health (EHC) Continues to Boost Presence in Florida
by Zacks Equity Research
Encompass Health (EHC) plans to construct an inpatient rehabilitation hospital in Florida in a bid to offer improved health outcomes across the state.
Is Select Medical (SEM) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Select Medical Holdings (SEM) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (SEM) Outperforming Other Medical Stocks This Year?
Here's Why You Should Add Molina Healthcare (MOH) Stock Now
by Zacks Equity Research
Molina Healthcare (MOH) appears a lucrative investment option at the moment backed by strategic initiatives and healthy revenue stream.
Anthem (ANTM) Buys MMM & Other Units From InnovaCare Health
by Zacks Equity Research
Anthem (ANTM) purchases subsidiaries of InnovaCare Health to facilitate better health outcomes across Puerto Rico.
Encompass Health (EHC), Altru Forms JV to Serve North Dakota
by Zacks Equity Research
Encompass Health (EHC) inks JV with Altru for sharing responsibility of operating the latter's inpatient rehabilitation hospital and offer better health outcomes across North Dakota.
What Makes Select Medical (SEM) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does Select Medical (SEM) have what it takes to be a top stock pick for momentum investors? Let's find out.
Select Medical (SEM) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Select Medical (SEM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Centene (CNC) Offers Senior Notes Priced at $1.8 Billion
by Zacks Equity Research
Centene (CNC) exhibits prudence in issuing notes to procure funds for executing the transaction of its Magellan Health acquisition.
Is Select Medical (SEM) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Select Medical (SEM) Is Attractively Priced Despite Fast-paced Momentum
by Zacks Equity Research
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Select Medical (SEM) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Select Medical's (SEM) Growth Plans to Extend US Footprint
by Zacks Equity Research
Select Medical (SEM) undertakes a series of buyouts and JVs aimed to offer an array of long-term acute care services for treating the U.S. population.
Select Medical (SEM) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
Select Medical (SEM) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
The Zacks Analyst Blog Highlights: UnitedHealth, Encompass Health, Select Medical Holdings and DaVita
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UnitedHealth, Encompass Health, Select Medical Holdings and DaVita
Save Your Portfolio From Inflation With Four Healthcare Stocks
by Zacks Equity Research
Healthcare stocks with long-term growth visibility can be important additions to investment portfolio when inflation runs high.
Humana's (HUM) Unit Unveils Centers for Serving South Louisiana
by Zacks Equity Research
Humana's (HUM) CenterWell brand introduces plans to open four centers offering enhanced healthcare services to South Louisiana's senior patients.
Here's Why Select Medical (SEM) is an Attractive Bet Now
by Zacks Equity Research
Select Medical's (SEM) northward analyst estimates and optimistic business prospects make it a lucrative stock to own for strong returns.
Here's How Much You'd Have If You Invested $1000 in Select Medical a Decade Ago
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Humana (HUM) to Buy onehome to Expand in Homehealth Care
by Zacks Equity Research
Humana (HUM) to take over One Homecare Solutions to establish its dominance in the home health business.
Select Medical (SEM) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Select Medical (SEM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.